Abiopharma

🔍 Carlile Robert Paul (Director)

Company: MICROVISION, INC. (MVIS)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 4,670 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 42,051.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,670 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: M | Expires: 2026-09-01 | Exercise: 2026-09-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
• F2: At vesting, converts into shares of common stock on a unit-for-share basis.
• F3: RSUs granted 07/16/2026 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date. The Form 4 filed on 07/17/2026 reports 280,152 RSUs granted on a pre-split basis, which equates to 18,677 on a post-split basis.